Neuraxis

NRXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$88.464 M

$7.09 +2.31%

Close of 7 Aug 2026

Revenue

$3.57M

#3353 by revenue

Earnings

-$7.80M

Loss-making

Shares outstanding

11,187,639

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#16HyperfineHYPR$94.8M
#17Outset MedicalOM$90.8M
#18NeuraxisNRXS$88.5M
#19StreamexSTEX$83.0M
#20electroCoreECOR$72.9M

Where these numbers come from

Share counts and financials for Neuraxis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.